Blazing the Trail to CERN, 1949-54

History of CERN: Vol. 1. Launching the European Organization for Nuclear Research. Armin Hermann, John Knge, Ulnke Mersits and Dominique Pestre. North-Holland, The Netherlands, 1987. Distributed in the United States and Canada by Elsevier Science Publishers, New York. 600 pp. $110. Since World War II, large laboratories have played an increasingly important role in hosting the world's largest and most expensive basic research projects. For example, the mammoth projects in large laboratories ha

Written byCatherine Westfall
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The volume, which covers the years 1949 to 1954, explores the scientific and cultural environment from which plans for CERN emerged, the founding of the laboratory, and the French, Italian, German and British decisions to join the organization. The authors will explore the first 12 years of CERN in the second volume.

A major strength of the book is its detailed attention to the sociological factors involved in science policy decision-making. Instead of providing a simplistic account of how CERN was proposed, the authors carefully trace the course of several independent initiatives, including the particularly influential proposals made by French science administrator Raoul Dautry and American physicist I.I. Rabi. They explain how multiple initiatives were fused without resolving differences between those, such as Dautry, who thought a particle physics program was too narrow, and others, including physicist Hendrick Kramers, who saw such a program as overly ambitious. The authors then ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies